Company News
Pfizer Shows 15% Weight Loss with Monthly Injection
Pfizer presented Phase 2b VESPER-1 data showing 15.9% body-weight reduction over eight months at highest weekly dose.
Phase 3-like VESPER-3 trial reported nearly 15% weight loss after 14 months with a
